Chimerix

Overcoming Deadly Diseases

At Chimerix, we are on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. With a current focus in oncology, we are devoted to filling gaps in the treatment paradigm.

Michael T.  Andriole

Michael T. Andriole

  • Board of Director
  • Chief Executive Officer (CEO)
  • President
Joshua E.  Allen

Joshua E. Allen

  • Chief Scientific Officer (CSO)
Michael A.  Alrutz

Michael A. Alrutz

  • Senior Vice President and General Counsel
Michelle  LaSpaluto

Michelle LaSpaluto

  • CFO: Chief Financial Officer
Allen  Melemed

Allen Melemed

  • Chief Medical Officer
Tom  Riga

Tom Riga

  • Chief Operating and Commercial Officer
Roy W.  Ware

Roy W. Ware

  • Chief Manufacturing and Technology Officer
Caryn  Barnett

Caryn Barnett

  • Vice President Clinical Operations
Tom  Brundage

Tom Brundage

  • Vice President Biostatistics
David  Jakeman

David Jakeman

  • VP Accounting and Finance
Christopher  Jordan

Christopher Jordan

  • Vice President Regulatory Affairs
Pablo  Lee

Pablo Lee

  • Vice President Medical Affairs
Odin  Naderer

Odin Naderer

  • Vice President Clinical Pharmacology and Translational Medicine
Eric  Turowski

Eric Turowski

  • Vice President Market Access, Distribution and Patient Services